Probiodrug has selected German CMO Rentschler to develop its Alzheimer’s monoclonal antibody candidate.
Demand for multiparticulate drug delivery systems has led Almac to add fluid-bed processing and encapsulation services to its pharma offering.
A proposed prescription drug price cap will lead to reductions in R&D spending and could have a negative knock-on effect for CROs say experts.
Recipharm will cut jobs to reduce costs after lower customer demand.
Trilantic Capital Partners Europe has bought a majority stake in Doppel Farmaceutici, citing the growth potential of Europe’s contracting market as the driver.
US compounder Pharmedium has recalled sterile drugs made with contaminated saline supplied by Pfizer's Hospira unit.